Pfizer to Sell Capsugel Unit to KKR for $2.38 Billion

REPLAY VIDEO
Your next video will start in
Pause

Recommended Videos

  • Info

  • Comments

April 4 (Bloomberg) -- Pfizer Inc., the world’s largest drugmaker, agreed to sell its Capsugel business to KKR & Co. for $2.38 billion in cash, said it will buy back additional shares and lowered its revenue forecasts. Bloomberg's Shannon Pettypiece reports. (Source: Bloomberg)

Advertisement

BTV Channel Finder

Channel_finder_loader

ZIP is required for U.S. locations

Bloomberg Television in   change